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Introduction
Tuberculosis (TB) is an infectious disease of high
prevalence in the world.  The World Health Organiza-
tion reported on estimated 8.8 million new TB cases
and 1.6 million people died of TB, in 2005 [1]. To gain
protection, people are vaccinated with live, attenuated
M. bovis BCG (Bacille Calmette Guérin) vaccine.  The
estimates of the BCG-induced protection against pul-
monary TB vary from 0 in South India to 80% in the
United Kingdom [2,3]. Nevertheless, the neonatal
BCG vaccination is associated with a significantly
lower incidence of TB in children. Moreover, BCG
protects against severe forms of childhood TB, espe-
cially meningeal and miliary TB. Usually, BCG vac-
cine induces also an acquired delayed type hypersensi-
tivity (DTH) to mycobacterial tuberculin proteins
[4,5]. Skin testing with purified tuberculin - PPD (puri-
fied protein derivative) is the only currently available
method of detecting BCG-induced DTH, in vivo. The
frequency of positive tuberculin skin tests (TST) in
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Abstract: Tuberculosis (TB) still remains the leading cause of mortality due to bacterial pathogen. The only currently avail-
able vaccine against TB, Bacille Calmette-Guérin (BCG) is at best credited with a 50% overall protective efficacy. Skin test-
ing with purified protein derivative (PPD) from Mycobacterium tuberculosis is the method of detecting BCG-induced cell
mediated immunity, in vivo. In the previous study we found that  approximately 60% young volunteers with no history of
TB, who had been subjected to neonatal BCG vaccination and revaccination(s) at school age, developed delayed type hyper-
sensitivity (DTH) to tuberculin. The remaining volunteers were persistently tuberculin negative. Moreover, we found a sig-
nificant association between BCG driven development of DTH to PPD and the polymorphism within the CD14 C/T(-159)
gene for macrophage receptor recognising mycobacterial compounds.  It has suggested that the CD14 gene variants may
play a role in the appearance and persistence of DTH to PPD in BCG vaccinated subjects. In order to extend our study on
a possible role of CD14 in BCG driven DTH response to PPD, we measured the expression of mCD14 on macrophages,
stimulated or not stimulated with mycobacterial antigens, and the serum levels of sCD14. Considering the importance of
CD14 - TLR2/TLR4 interactions in macrophage signalling, we determined the polymorphism of TLR2 and TLR4 genes as
well as macrophage expression of TLR2 for the volunteers with and without skin reactivity to PPD. We observed a subtle
but significant decrease in CD14 density on adherent monocytes from tuberculin positive versus tuberculin negative volun-
teers. However, we found no difference in CD14 density on monocytes enriched in CD14+ cells using anti-CD14 mAb cou-
pled to magnetic beads. A significant increase in CD14 density was observed on macrophages stimulated with PPD and LPS
but not with live BCG bacilli. However, this increase as well as serum levels of soluble sCD14 were similar in the volun-
teers with and without skin reactions to PPD. Thus, our suggestion on the role of CD14 in the generation of DTH to tuber-
culin in BCG vaccinated subjects should be further explored. The most important CD14 co-receptors are Toll-like receptors
(TLRs) which activate nuclear factors for the production of inflammatory cytokines. However,  we could see no association
between the polymorphisms of  TLR4 (Asp299Gly and Thr399Ile)  and TLR2 genes (Arg753Gln and Arg677Trp) and skin
responses to PPD. Also, the TLR2 density was similar on monocytes from tuberculin negative and tuberculin positive vol-
unteers. 
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previously BCG-vaccinated individuals has varied
greatly depending on the population under the study
[6]. In our study, positive tuberculin tests were
observed for approximately 60%  young volunteers
with no history of TB, who had been subjected to
neonatal BCG vaccination and revaccination(s) at
school age. The remaining volunteers were persistent-
ly tuberculin negative [7]. Then, we found a significant
association between the BCG driven development of
DTH to tuberculin and the polymorphism within the
promoter region of CD14 C/T(-159) gene [8]. The
prevalence of CC genotype was significantly higher
among tuberculin positive as compared with tuber-
culin negative volunteers. It has suggested that the
CD14 gene variants may play a role in the appearance
and persistence of DTH to PPD in the individuals sub-
jected to BCG vaccination. 
CD14 is a glycoprotein with 356 amino acids
encoded on chromosome 5q 23-31, which exists in
human in two forms: soluble sCD14 in the serum and
cerebrospinal fluid and membrane mCD14 on the sur-
face of mature myeloid cells [9]. It has been reported
recently that the CD14 C/T(-159) polymorphism is
located at a GC box near the transcription start site,
which serves as a binding site for Sp1-Sp2/Sp3 tran-
scription factors that are involved in the regulation of
CD14 gene transcription [10]. As a major lipopolysac-
charide (LPS) binding protein, CD14 plays a critical
role in the response to LPS of Gram-negative bacteria.
In addition, CD14 can bind other microbial products
such as peptidoglycan, lipoteichoic acid, lipoproteins
and lipoarabinomannan (LAM) derived from
Mycobacterium [11,12]. CD14 has been known to be
associated with Toll-like receptors (TLRs). CD14 as
well as TLRs are pattern recognition receptors (PRRs)
which recognize the structural compounds of bacteria
at the first steps of the infection. The macrophage
PRRs are innate immune sensors for conservative mol-
ecules of organisms ranging from bacteria to fungi,
protozoa and viruses, and they regulate mucosal
inflammation and contribute to controlling host
defense against infective agents [9,13]. CD14 interacts
with Toll-like receptors, TLR-4 and TLR-2, to transmit
cell signals [11,14-17]. Several reports have described
a TLR2 dependent cell activation by mycobacterial
cell wall lipoglicans, especially by phosphoinosytol-
capped LAM (PILAM), phosphatidyl myo-innositol
mannosides (PIM)2, PIM6 and 19kDa lipoprotein. On
the other hand, there are data suggesting that  poly-
morphism in the TLR2 gene at residue Arg753Gln
leads to a decreased response of macrophages to bac-
terial peptides, resulting in an attenuated immune
response in the host [18]. These data suggest that
TLR2 is crucially involved in the immune response to
mycobacteria [19]. Macrophages use CD14 and TLR2
to recognize mycobacterial compounds and produce
cytokines that regulate cellular antimycobacterial
immune response [16]. 
In this paper, we extended our study on a possible
role of CD14 in BCG driven DTH response to PPD.
For tuberculin positive and tuberculin negative BCG
vaccinated volunteers we measured the expression of
mCD14 on macrophages, stimulated or not stimulated
with mycobacterial antigens, and the serum levels of
sCD14. Considering the importance of CD14 -
TLR2/TLR4 interactions in macrophage signalling, we
determined the polymorphism of TLR2 and TLR4
genes as well as macrophage expression of TLR2 for
the volunteers with and without skin reactivity to PPD.
Materials and methods
Study volunteers. The study was performed for 154 healthy young
(18-27 years) volunteers, who had been subjected to BCG vacci-
nation according to the state policy. All individuals had been sub-
jected to neonatal BCG vaccination. BCG revaccinations were
given to those who were tuberculin negative after Mantoux testing
with PPD. In this paper all volunteers were screened for DTH to
PPD. None of the volunteers had a history of TB. 
Monocytes. PBML (peripheral blood mononuclear leukocytes)
were isolated from heparinised blood by density gradient centrifu-
gation on Histopaque 1077 (Sigma) [20]. The cell suspension was
enriched in adherent monocytes by an incubation in plastic glass
culture plate (1.5 h at 37°C in 5% CO2), in culture medium (RPMI-
1640 medium, 10% heat-inactivated fetal calf serum, 2mM L-glu-
tamine, 5 ug/ml gentamicin). Membrane CD14 density was deter-
mined on freshly isolated adherent monocytes from 29 volunteers,
tuberculin negative (16) and positive (13). In some experiments,
adherent monocytes (1×106/ml) were stimulated (48 h at 37°C in
5% CO2) with 1×10
6/ml live M. bovis BCG bacilli (Biomed,
Lublin, Poland), 10 μg/ml PPD (Statens Serum Institute, Den-
mark), 1 μg/ml E. coli LPS (Sigma) or in culture medium alone, in
24 wells culture plates. Considering the heterogeneity of mono-
cytes/ macrophage population we used more selective magnetic
micro-beads (MACS--Miltenyi Biotec) method for preparation of
CD14+ monocytes. PBML were isolated from heparinised blood of
23 volunteers, tuberculin negative (12) and positive (11), by cen-
trifugation on Ficoll-PaqueTM (Amersham Bioscience) and then
positively enriched in CD14+ cells using MACS technique [21].
The expression of mCD14 and TLR2 receptors on those cells was
determined by immunofluorescence. 
Membrane expression of mCD14 and TLR2. For direct flow
cytometric analysis the monocytes/macrophages (105 cells) were
stained with  3 μl  FITC labelled mouse anti-human mCD14 mAb
(CD14-FITC and FITC mouse IgG2 - negative control, from Bec-
ton Dickinson) and 5 μl phycoerythrin-conjugated mouse anti-
human TLR2 mAb (TLR2-PE and PE labelled mouse IgG2 - neg-
ative control, from eBioscience) according to manufacturers. After
two washes, the cells were analysed by flow cytometry using a
FACScan (Becton Dickinson) and (FlowJo software 7.2.2, Tree
Star, Inc., USA). The numbers of cell analysis counts were 10000
events per tube. The density of the receptors on monocytes was
expressed as median fluorescent intensity (MFI) of sample with
anti-CD14 or anti-TLR2 mAb diminished by MFI value of isotype-
matched negative control.
Serum sCD14. The concentration of soluble sCD14 in the serum
from 55 tuberculin negative and 72 tuberculin positive individuals
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was assessed using an enzyme-linked immunosorbent assay (sCD14
Human Quantikine Kit (R&D, MN, USA). The optical density (OD)
of each sample was determined by using a multifunctional counter
Victor 2 (Wallack Oy, Turku, Finland) set at 450 nm.
TLR4 and TLR2 genes polymorphisms. Genomic DNA was
obtained from 200 μl of EDTA-anti-coagulated blood using Qiamp
DNA MiniKit (Qiagen, Hilden, Germany) according to manufac-
turers instructions. Two known functionally important single
nucleotide polymorphisms (SNPs) within TLR4 gene (Asp299Gly
and Thr399Ile) were investigated by RFLP-PCR (restriction frag-
ment length polymorphism-polymerase chain reaction). We
analysed TLR4 Asp299Gly polymorphism using primers: forward
5’- GAT TAG CAT ACT TAG ACT ACT ACC TCC ATG -3’ and
reverse 5’- GAT CAA CTT CTG AAA AAG CAT TCC CAC -3’.
DNA fragments were digested with NcoI (Fermentas). The TLR4
Thr399Ile polymorphism was analysed using primers: forward 5’-
GGT TGC TGT TCT CAA AGT GAT TTT GGG AGA A-3’ and
reverse 5’- CCT GAA GAC TGG AGA GTG AGT TAA ATG CT
3’ and HinfI (Fermentas) [22] Genotyping for TLR2 Arg753Gln
and TLR2 Arg677Trp variants was performed by RFLP-PCR. To
detect the mutation at codon 753 a fragment of DNA was amplified
using  the primers: forward 5?-CCT ACT GGG TGG AGAACC T-
3’ and reverse 5’-GGC CAC TCC AGG TAG GTC TT-3’ RFLP
was performed using AciI restriction enzyme (Fermentas) [23]. 
Tuberculin Skin Test. Tuberculin RT23 (2 IU) was injected intra-
dermally in the forearm of BCG-vaccinated volunteers. An indura-
tion of at least 10 mm was considered as a positive tuberculin test.
Ethical issues. The study was approved by the Human Ethics
Committee.
Statistical analysis. The analyses were performed using Statistica
5.0 (Statsoft). A comparison between the various genotypes in TT+
and TT- volunteers was made using the chi-square test. A compar-
ison of mean values for sCD14 and median values for mCD14 and
TLR2 MFI (median fluorescent intensity) was made by Mann-
Whitney U-test. A p value  0.05 was considered significant.
Results
CD14 receptors
In healthy humans, the monocytes consist 1-5% of
leukocytes. The CD14 is a specific marker of mono-
cyte/macrophage cell population. To measure the
expression of CD14 on monocytes  we prepare PBML
suspensions enriched in monocytes. Two methods
were used for this purpose. By the adherence of PBML
to plastic glass we obtained the cell suspension of
adherent monocytes. On average, 79% adherent mono-
cytes were stained for CD14 antigen. There was no
significant difference in the percentage of CD14+ cells
in adherent monocytes from tuberculin negative
(81±7) and tuberculin positive (75±11) volunteers.
However, CD14 density was slightly higher on native
adherent monocytes from tuberculin negative
(449.2±84.7) than tuberculin positive (378.3±70.4)
volunteers. This difference was significant (p=0.0317)
(Table 1). By magnetic positive separation with CD14
specific mAb we obtained more homogenous mono-
cyte suspensions composed of 95±4% CD14+ (tuber-
culin positive group) and 96±4% CD14+ (tuberculin
negative group) monocytes. We observed no signifi-
cant difference in CD14 density on magnetic separat-
ed monocytes from tuberculin negative (6533.9±
1761.4) and tuberculin positive (6201.4±1090.6) vol-
unteers (Table 2). 
The significant difference in mCD14 density on
native adherent monocytes from tuberculin positive
and tuberculin negative BCG vaccinated volunteers
prompted us to measure the expression of this receptor
on the cells stimulated with mycobacterial antigens
and LPS as a positive control. The adherent monocytes
from volunteers responded to PPD and LPS by a sig-
nificant increase in mCD14 density (Fig. 1), however,
the response of the macrophages from tuberculin pos-
itive and tuberculin negative subjects was almost
equally intensive (Fig. 2). On the contrary, we did not
observe any effect of live BCG bacilli on the expres-
sion of mCD14 on the surface of stimulated
macrophages. Then, the levels of sCD14 in the serum
from 55 tuberculin negative and 72 tuberculin positive
individuals were tested by ELISA. The average con-
centration of sCD14 in the sera from tuberculin nega-
tive and tuberculin positive volunteers was almost the
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Table 1. Membrane CD14 density on native adherent monocytes from tuberculin negative and tuberculin positive volunteers.
Table 2. Membrane CD14 density on magnetic separated monocytes from tuberculin negative and tuberculin positive volunteers.
same: 1461±420 ng/ml and 1475±483 ng/ml, respec-
tively. We previously reported [7] that there was no
association between the serum sCD14 levels and
CD14 C/T (-159) promoter polymorphism. In this
paper, we could see no correlation between the serum
sCD14 concentration and mCD14 density on adherent
(r=0.008, p=0.97) or magnetic separated (r=-0.06,
p=0.7865) monocytes, either in tuberculin positive or
tuberculin negative group.
Toll-like receptors (TLRs)
Our aim was to investigate whether the presence of
TLR4 and TLR2 polymorphisms had any influence on
the development of DTH to PPD in BCG vaccinated
volunteers. We studied TLR4 Asp299Gly and TLR4
Thr399Ile polymorphisms for  tuberculin negative (62
and 61 respectively) and tuberculin positive subjects
(82 and 81 respectively) (Table 3). Both groups were
in Hardy - Weinberg equilibrium at the polymorphic
loci studied. The TLR4 Asp299Gly and TLR4
Thr399Ile polymorphisms were in linkage disequilib-
rium as it had been reported earlier [24]. The frequen-
cies of mutated alleles (homozygous and heterozy-
gous) were compared between the volunteers with and
without DTH to PPD. We found no significant differ-
ence for TLR4 Asp299Gly and TLR4 Thr399Ile muta-
tions between tuberculin negative (13%) and tuber-
culin positive (5%) subjects. Also, we investigated
TLR2 Arg677Trp and TLR2 Arg753Gln for 62 tuber-
culin negative and 79 tuberculin positive volunteers.
The TLR2 Arg667Trp polymorphism did not occur in
the volunteers under the study. This is consistent with
the results of the previous studies which identified no
individuals carrying this polymorphism in Caucasians
[23]. The distribution of  the TLR2 Arg753Gln poly-
morphism is presented in Table 3. The study groups
were in Hardy-Weinberg equilibrium. The TLR2
Arg753Gln polymorphism is rare among Poles and
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Fig. 1. Representative data on staining of adherent monocytes with
CD14-FITC mAb. The monocytes were incubated for 48 h in
medium alone (unstimulated cells) or they were stimulated with  E.
coli LPS or PPD from M. tuberculosis. 
Fig. 2. The CD14 density on adherent monocytes from tuberculin
negative (TT-) and tuberculin positive (TT+) volunteers. The cells
were incubated for 48 h in medium alone (unstimulated cells), or
they were stimulated with  E. coli LPS, PPD from M. tuberculosis
or live M. bovis BCG bacilli.  
there was no significant difference in the percentage of
homozygous Arg753Arg and heterozygous Arg753Gln
genotypes in the group of tuberculin negative (97 and
3%, respectively) and tuberculin positive (94 and  6%,
respectively) volunteers. The Gln753Gln homozygotes
did not occur among the subjects included in the study.
Then, the level of TLR2 was measured on the surface
of magnetic separated monocytes from 23 volunteers,
tuberculin negative (12) and positive (11).  The aver-
age TLR2 density was similar on the cells from tuber-
culin negative (142.1 61.7) and tuberculin positive
168.3 152.6) volunteers (p>0.05) (Table 4). 
Discussion
Today, more than three billion people have been vacci-
nated with the attenuated M. bovis BCG bacilli [25].
However TB remains the leading cause of mortality
due to bacterial pathogen [1]. There is a general con-
sensus that BCG vaccine is credited with a 50% over-
all protective efficacy [26]. The immune responses to
BCG bacilli are greatly influenced by the host cellular
immune system, however, the exact role of effector
mechanisms in cellular response to BCG vaccine
remains to be fully established. Skin testing with PPD
is the only currently available method of detecting
BCG-induced cell-mediated immunity, in vivo. In our
study, only about 60% of BCG vaccinated young
healthy volunteers showed DTH to PPD. Recently we
found that the CD14 polymorphism might play a sig-
nificant role in regulating the appearance and the size
of the tuberculin reaction in BCG vaccinated individu-
als [8]. The prevalence of CC genotype of CD14 C(-
159)T gene was significantly higher among tuberculin
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Table 3. Distribution of TLR4 and TLR2 polymorphisms among tuberculin negative and tuberculin positive volunteers
Table 4. Membrane TLR2 density on magnetic separated monocytes from tuberculin negative and tuberculin positive volunteers.
positive as compared with tuberculin negative sub-
jects. CD14, a pattern recognition receptor on mono-
cytes and macrophages, recognises bacterial structures
and initiates inflammatory response [13,16]. In this
study, we observed a subtle but significant decrease in
mCD14 density on monocytes from tuberculin posi-
tive versus tuberculin negative volunteers while the
cells were  separated by the adherence to plastic glass.
However, CD14+ monocytes obtained by positive
magnetic separation from PPD responders and nonre-
sponders showed a very similar mCD14 density. This
discrepancy could be explained by a heterogeneity of
monocytes/macrophages. A proportion of adherent
monocytes with very low if any mCD14 expression
could be present in  higher numbers among monocytes
from tuberculin positive than tuberculin negative vol-
unteers. This type of monocytes could be absent from
the suspensions of positively magnetic separated
CD14+ cells. A lower stability of mCD14 on the sur-
face of freshly separated adherent monocytes from
PPD responders as compared with PPD nonresponders
should not be excluded. This suggestion seems to be
confirmed by a similar CD14 density on adherent
monocytes  from tuberculin positive and tuberculin
negative volunteers, in 48h cultures. An involvement
of CD14 receptor in the interaction of macrophages
with mycobacteria is documented by the significant
increase in mCD14 density on adherent monocytes
stimulated with PPD for 48h. But, there was no differ-
ence in the PPD driven increase in CD14 density on
monocytes from tuberculin positive and tuberculin
negative subjects. Also, very similar levels of  soluble
CD14 were detected in the sera from the subjects with
and without DTH to PPD. Thus, our suggestion on the
role of CD14 in the development of delayed type
hypersensitivity to tuberculin in BCG vaccinated indi-
viduals should be further explored. 
The most important CD14 co-receptors are TLR2
and TLR4, which activate nuclear factors and inflam-
matory pathway resulting in the production of
cytokines important in the immune responses to
mycobacteria [17,19]. Moreover, the TLR2 Arg677Trp
polymorphism was found to be associated with sus-
ceptibility to tuberculosis in Tunisians [27]. However,
the TLR2 Arg677Trp polymorphism previously
reported among Koreans and Tunisians did not occur
among Caucasian volunteers included in  the study.
Similarly, it was not found among Germans [23].
Another polymorphism located in the Toll IL-1R
domain of human TLR2, Arg753Gln, was shown to be
associated with lower IL-12 levels in lepromatous lep-
rosy patients [28]. Thus, this polymorphism of TLR2
gene could lead to attenuated DTH development in M.
bovis BCG vaccinated subjects because IL-12 depend-
ent IFN-  pathway is  known to be crucial in cellular
immunity to mycobacteria. However, we observed no
significant correlation between the TLR2 Arg753Gln
polymorphism, TLR2 expression on adherent mono-
cytes, and the occurrence of DTH responses to PPD in
BCG vaccinated volunteers.
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